GFRC Enhance Patient Satisfaction and Reduce Complications in Maxillary Implants With Pekkton Frameworks

Launched by CAIRO UNIVERSITY · Aug 29, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how a special type of temporary dental framework, made from glass fiber composite, can improve patient satisfaction and reduce complications for people getting maxillary implants. Specifically, the researchers want to see how this temporary framework affects patients before they receive a final, more durable framework made from a material called PEKKTON. The study will follow participants for one year to gather information on their experiences and any issues that arise.

To be eligible for this trial, participants should be adults aged 40 to 65 who have lost all their teeth in the upper jaw and have a specific jaw alignment. They need to have enough healthy gum tissue and bone for the implants and must practice good oral hygiene. However, individuals with certain conditions, like recent tooth extractions, infections, uncontrolled diabetes, or those who smoke heavily, will not be able to participate. If someone joins the trial, they can expect to receive a temporary dental framework and will be monitored over the next year to see how well it works before moving on to the final dental solution.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • a. Completely edentulous patients with Angle's Class I maxillomandibular relationship b. Age ranges from 40 to 65 years old. c. Adequate zone of keratinized attached mucosa (≥ 8mm) over the maxillary crest.
• • d. Absence of any medical disorder that could complicate the surgical phase or affect osseointegration.
• • e. The patient must have enough bone height for implants, a minimum length of bone f. 12 mm, and a minimum diameter of bone 6 mm. g. Patients with good oral hygiene. h. Complete denture wearer. i. Adequate interarch space for screw-retained prosthesis. j. Absence of any intra-oral pathological condition.
• Exclusion Criteria:
• • - a. Patients with recent extraction (less than three months). b. Patients with an inflamed ridge or candida infection c. Patients with the flabby ridge. d. Para functional habits. e. Cancer patients receiving chemotherapy and/or radiotherapy. f. Patients with uncontrolled diabetes, assessed by measuring glycosylated hemoglobin (HbA1c ≥ 7) g. Potentially uncooperative patients who are not willing to go through the proposed interventions.
• • h. Moderate-to-heavy daily smokers (more than ten per day)